How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?

Nick Freemantle

Research output: Contribution to journal › Article

40 Citations (Scopus)

Original language	English
Pages (from-to)	836-838
Number of pages	3
Journal	British Medical Journal
Volume	331
Issue number	7520
DOIs	https://doi.org/10.1136/bmj.331.7520.836
Publication status	Published - 8 Oct 2005

Access to Document

10.1136/bmj.331.7520.836

Cite this

@article{1d9244a8988240c692a3f09700ab32fe,

title = "How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?",

author = "Nick Freemantle",

year = "2005",

month = oct,

day = "8",

doi = "10.1136/bmj.331.7520.836",

language = "English",

volume = "331",

pages = "836--838",

journal = "British Medical Journal",

issn = "1468-5833",

publisher = "BMJ Publishing Group",

number = "7520",

}

TY - JOUR

T1 - How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?

AU - Freemantle, Nick

PY - 2005/10/8

Y1 - 2005/10/8

U2 - 10.1136/bmj.331.7520.836

DO - 10.1136/bmj.331.7520.836

M3 - Article

C2 - 16210286

SN - 1468-5833

SN - 1756-1833

VL - 331

SP - 836

EP - 838

JO - British Medical Journal

JF - British Medical Journal

IS - 7520

ER -